The Blueprint Genetics Autism Spectrum Disorders Panel is a 13 gene test for genetic diagnostics of patients with clinical suspicion of autism spectrum disorder or syndromic autism.Read more
NeurologyWe offer comprehensive genetic diagnostics for all the main hereditary neurological disorders. These diseases include syndromic and nonsyndromic epilepsies, ataxias, amyotrophic lateral sclerosis, hereditary polyneuropathies and motor neuron diseases, limb girdle muscular dystrophies, leukodystrophies, mental retardation, Parkinson’s disease, and dementia, among others.
Genetic testing for neurology
Genetic testing in the field of neurology is becoming increasingly beneficial. NGS panels can lead to a notable increase in the diagnostic success rate, as well as potentially more rapid diagnoses, which has implications for health service economics and improved patient satisfaction.
Genetic testing using targeted capture followed by NGS is an efficient and cost-effective method of molecular diagnosis in many refractory ataxia cases (PMID: 24030952). Furthermore, genetic diagnosis using well-designed NGS panels has expanded the phenotypic spectrum of many genes to cover a broader range of diseases than ever before. With the current technology and careful interpretation of the detected variants, mutations in the same genes can be associated with a broad range of clinical and neuroimaging phenotypes.
What genetic diagnostics can offer patients with neurological diseases
All of the main neurological disease categories have a large number of subtypes with extensive phenotypic overlap, which complicates traditional clinical diagnosis. For example, disorders that were thought to be separate entities may actually represent a phenotypic continuum of a single entity, as was shown with Bethlem myopathy and Ullrich congenital muscular dystrophy. Genetic diagnostics is the most efficient way to subtype neurological diseases, and provides the necessary information to make confident individualized treatment and management decisions.
Living with a set of symptoms and findings without a definitive diagnosis can be stressful for patients, so finding a genetic cause may end a long diagnostic odyssey, and in many cases, a definite name may be relieving. Genetic diagnosis in neurological diseases has significant prognostic value, as disease progression can often be evaluated based on the underlying genetic defect.
A selection of our neurology panels
The Blueprint Genetics Nemaline Myopathy Panel is an 11 gene test for genetic diagnostics of patients with clinical suspicion of nemaline myopathy.Read more
Find the right test for your patient
Published on June 21, 2017
Blueprint Genetics is committed to provide the highest quality genetic testing for our customers. Blueprint Genetics is committed to provide the highest quality genetic testing for our customers. Since quality is something that can be proven, we are proud to transparently share our full set of quality metrics with you. To be…Read more
Published on June 15, 2017
There is a significant completion to drive down the price and TAT of genetic diagnostics. To survive in this competition, laboratories have to either rigorously innovate or then make compromises in quality and performace standards. In an untransparent diagnostic environment, health care professionals have a hard time to evaluate optimal and best testing for their patients.
[WHITE PAPER] Validation of clinical testing – Setting a new standard for clinical testing through fully transparent validation. Comprehensive analytic validation is a critical step in transparent genetic diagnostics. It demonstrates the quality and performance of the pipeline, and is the foundation for setting quality standards for the carried tests. Blueprint Genetics performs analytic…Read more